hide message

Welcome to the Resource Centre

We make it our mission to work with advocates in civil society, business and government to address inequalities of power, seek remedy for abuse, and ensure protection of people and planet.

Both companies and impacted communities thank us for the resources and support we provide.

This is only possible because of your support. Please make a donation today.

Thank you,
Phil Bloomer, Executive Director

Donate now hide message

Acesso a medicamentos

Get RSS feed of these results

Related stories and components

Article
19 April 2017
+ Français - Hide

Author: Bilan (Suisse)

« Novartis accusé de pression sur la Colombie », 12 avril 2017...

Read more

Article
12 April 2017

Colombia: Leaked documents reveal Novartis threatened govt. with intl. investment arbitration over licensing of pharmaceutical patents

Author: Public Eye

"Compulsory licensing in Colombia: Leaked documents show aggressive lobbying by Novartis", 11 Apr 2017...

Read more

Article
6 February 2017

Commentary: Embracing access to medicines can be beneficial for pharmaceutical companies' business & reputation

Author: Damiano de Felice, Access to Medicines Index, on Harvard Business Review

"How Pharma Can Fix Its Reputation and Its Business at the Same Time", 3 Feb 2017...

Read more

Article
31 January 2017

USA: Diabetes patients sue Novo Nordisk, Sanofi, & Eli Lilly for alleged insulin price-fixing

Author: Lydia Ramsey, Business Insider (UK)

"The makers of insulin are being accused of price-fixing in a class-action lawsuit", 30 Jan 2017...

Read more

Article
26 January 2017
+ Português - Hide

Author: Grupo de Trabalho sobre Propriedade Intelectual-GTPI (Brazil)

“INPI rejeita pedido de patente do Truvada® no Brasil-Com a decisão, a combinação de medicamentos que atua na prevenção do HIV passa a fazer parte do domínio público”, 24 de janeiro de 2017...

Read more

Story
17 January 2017

The role of business in implementing the UN Sustainable Development Goals - new reports

See full story

Article
16 January 2017

Council of Europe report addresses challenges posed to children's rights by scientific & technological developments in biomedicine

Author: Council of Europe & Uppsala University

The Committee on Bioethics (DH-BIO) published a study prepared at its request by researchers from Uppsala University Department of Law (Sweden) on the challenges posed to the rights of the child by scientific and technological developments in...

Read more

Report
9 January 2017
+ Deutsch - Hide

Author: Deutsches Institut für Menschenrechte

“Entwicklung der Menschenrechtssituation in Deutschland: Januar 2015 – Juni 2016 - Bericht an den deutschen Bundestag“...

Read more

Article
30 November 2016
+ Português - Hide

Author: Grupo de Trabalho sobre Propriedade Intelectual-GTPI (Brazil)

“Conquista histórica: Audiência Regional sobre a falta de acesso a medicamentos, um crime silencioso”, 23 de novembro de 2016...

Read more

Story
16 November 2016

Pfizer lowers price of pneumococcal vaccine, but MSF seeks long-term commitment to access to medicine

See full story